On December 23, 2022, in Tashkent, in the conference hall of the FRANKFORT Hotel, the Association of Hepatologists of Uzbekistan together with the Association of Biomedical Technologies, with the support of the domestic biotechnology company ROSSA LLC, held a round table on the topic: “Innovative technologies in the diagnosis of chronic hepatitis B”.
The event was attended by employees of the Research Institute of Virology RSNPMTSEMIPZ, the Republican Specialized Scientific and Practical Medical Center of Epidemiology, Microbiology, Infectious and Parasitic Diseases, as well as infectious diseases and laboratory specialists of Uzbekistan.
Within the framework of the round table , presentations were made:
Director of the Research Institute of Virology Musabaev E.I.
Hegai T. R. – Director of Production of ROSSA LLC.
Kan N.G. is a virologist at the Reference Laboratory of the Research Institute of Virology.
The purpose of the event is to discuss the latest achievements in the diagnosis of an extremely important problem for Uzbekistan and other Central Asian countries – chronic viral hepatitis B.
Also, the specialists were presented with the latest method of diagnosing the disease, which detects the RNA of the hepatitis B virus in the blood. The method allows you to establish the latent form of hepatitis B without performing such a complex procedure as a liver biopsy.